 | Up a level |
Person, Fermin; Meyer, Sara C.; Hopfer, Helmut; Menter, Thomas (2021). Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms. Virchows Archiv, 479(5), pp. 1013-1020. Springer 10.1007/s00428-021-03129-y
Stivala, Simona; Meyer, Sara C. (2021). Recent Advances in Molecular Diagnostics and Targeted Therapy of Myeloproliferative Neoplasms. Cancers, 13(20) MDPI AG 10.3390/cancers13205035
Szybinski, Jakub; Meyer, Sara C. (2021). Genetics of Myeloproliferative Neoplasms. Hematology/oncology clinics of North America, 35(2), pp. 217-236. Elsevier 10.1016/j.hoc.2020.12.002
Brkic, Sime; Meyer, Sara C. (2021). Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms. HemaSphere, 5(1), e516. Wolters Kluwer Health 10.1097/HS9.0000000000000516
Nienhold, Ronny; Ashcroft, Peter; Zmajkovic, Jakub; Rai, Shivam; Rao, Tata Nageswara; Drexler, Beatrice; Meyer, Sara C.; Lundberg, Pontus; Passweg, Jakob R; Leković, Danijela; Čokić, Vladan; Bonhoeffer, Sebastian; Skoda, Radek C (2020). MPN patients with low mutant JAK2 allele burden show late expansion restricted to erythroid and megakaryocytic lineages. Blood, 136(22), pp. 2591-2595. American Society of Hematology 10.1182/blood.2019002943
Meyer, Sara C.; Drexler, Beatrice; Skoda, Radek C. (2019). [Myeloproliferative neoplasms - Update on diagnosis and treatment]. Therapeutische Umschau. Revue therapeutique, 76(9), pp. 487-495. Hogrefe 10.1024/0040-5930/a001128
Kunimoto, Hiroyoshi; Meydan, Cem; Nazir, Abbas; Whitfield, Justin; Shank, Kaitlyn; Rapaport, Franck; Maher, Rebecca; Pronier, Elodie; Meyer, Sara C.; Garrett-Bakelman, Francine E; Tallman, Martin; Melnick, Ari; Levine, Ross L; Shih, Alan H (2018). Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity. Cancer cell, 33(1), 44-59.e8. Cell Press 10.1016/j.ccell.2017.11.012
Nitulescu, Ioana I; Meyer, Sara C.; Wen, Qiang Jeremy; Crispino, John D; Lemieux, Madeleine E; Levine, Ross L; Pelish, Henry E; Shair, Matthew D (2017). Mediator Kinase Phosphorylation of STAT1 S727 Promotes Growth of Neoplasms With JAK-STAT Activation. EBioMedicine, 26, pp. 112-125. Elsevier 10.1016/j.ebiom.2017.11.013
Stivala, Simona; Gobbato, Sara; Infanti, Laura; Reiner, Martin F; Bonetti, Nicole; Meyer, Sara C.; Camici, Giovanni G; Lüscher, Thomas F; Buser, Andreas; Beer, Juerg H (2017). In response to the comment by Hechler et al.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance. Haematologica - the hematology journal, 102(12), e504-e505. Ferrata-Storti Foundation 10.3324/haematol.2017.181818
Stivala, Simona; Gobbato, Sara; Infanti, Laura; Reiner, Martin F; Bonetti, Nicole; Meyer, Sara C.; Camici, Giovanni G; Lüscher, Thomas F; Buser, Andreas; Beer, Jürg H (2017). Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance. Haematologica - the hematology journal, 102(10), pp. 1650-1660. Ferrata-Storti Foundation 10.3324/haematol.2017.164137
Meyer, Sara C. (2017). Mechanisms of Resistance to JAK2 Inhibitors in Myeloproliferative Neoplasms. Hematology/oncology clinics of North America, 31(4), pp. 627-642. Elsevier 10.1016/j.hoc.2017.04.003
Meyer, Sara C.; Steinmann, Eva; Lehmann, Thomas; Muesser, Patricia; Passweg, Jakob R; Skoda, Radek C; Tsakiris, Dimitrios A (2017). Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera. BioMed research international, 2017, p. 9876819. Hindawi 10.1155/2017/9876819
Shimizu, Takafumi; Kubovcakova, Lucia; Nienhold, Ronny; Zmajkovic, Jakub; Meyer, Sara C.; Hao-Shen, Hui; Geier, Florian; Dirnhofer, Stephan; Guglielmelli, Paola; Vannucchi, Alessandro M; Feenstra, Jelena D Milosevic; Kralovics, Robert; Orkin, Stuart H; Skoda, Radek C (2016). Loss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis. The Journal of experimental medicine, 213(8), pp. 1479-1496. Rockefeller Univ. Press 10.1084/jem.20151136
Meyer, Sara C.; Medinger, Michael; Halter, Jörg P; Baldomero, Helen; Hirsch, Hans H; Tzankov, Alexandar; Dirnhofer, Stephan; Passweg, Jakob R; Tichelli, André (2014). Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation. Hematology, 19(5), pp. 280-285. Taylor & Francis 10.1179/1607845413Y.0000000123
Waibel, Michaela; Solomon, Vanessa S; Knight, Deborah A; Ralli, Rachael A; Kim, Sang-Kyu; Banks, Kellie-Marie; Vidacs, Eva; Virely, Clemence; Sia, Keith C S; Bracken, Lauryn S; Collins-Underwood, Racquel; Drenberg, Christina; Ramsey, Laura B; Meyer, Sara C.; Takiguchi, Megumi; Dickins, Ross A; Levine, Ross; Ghysdael, Jacques; Dawson, Mark A; Lock, Richard B; ... (2013). Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors. Cell reports, 5(4), pp. 1047-1059. Cell Press 10.1016/j.celrep.2013.10.038
Meyer, Sara C.; O'Meara, Alix; Buser, Andreas S; Tichelli, André; Passweg, Jakob R; Stern, Martin (2013). Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation. Biology of blood and marrow transplantation, 19(3), pp. 440-444. Elsevier 10.1016/j.bbmt.2012.10.012
Forestier, Marc; Al-Tamimi, Mohammad; Gardiner, Elizabeth E; Hermann, Corinna; Meyer, Sara C.; Beer, Juerg H (2012). Diesel exhaust particles impair platelet response to collagen and are associated with GPIbα shedding. Toxicology in vitro, 26(6), pp. 930-938. Elsevier 10.1016/j.tiv.2012.04.009
